Planned Trial: Anti-chemokine receptor 4 Chimeric Antigen Receptor cells

by | May 3, 2022 | Clinical Trials

Planned trial:

  • Phase I trial of anti-chemokine receptor 4 Chimeric Antigen Receptor cells (CCR4-CARs) for the treatment of CCR4 expressing T-cell malignancies

Other guidelines and trials you may be interested in…